N-[2-[3-Methoxy-4-(phenylMethoxy)phenyl]ethyl]-4-(phenylMethoxy)benzeneacetaMide
![N-[2-[3-Methoxy-4-(phenylMethoxy)phenyl]ethyl]-4-(phenylMethoxy)benzeneacetaMide price.](/CAS/20150408/GIF/132257-11-5.gif)
|
- $650 - $1320
- Product name: N-[2-[3-Methoxy-4-(phenylMethoxy)phenyl]ethyl]-4-(phenylMethoxy)benzeneacetaMide
- CAS: 132257-11-5
- MF: C31H31NO4
- MW: 481.58
- EINECS:
- MDL Number:
- Synonyms:N-[2-[3-Methoxy-4-(phenylMethoxy)phenyl]ethyl]-4-(phenylMethoxy)benzeneacetaMide;N-[2-(3-methoxy-4-phenylmethoxyphenyl)ethyl]-2-(4-phenylmethoxyphenyl)acetamide;Benzeneacetamide, N-[2-[3-methoxy-4-(phenylmethoxy)phenyl]ethyl]-4-(phenylmethoxy)-
2 prices
Selected condition：
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 50mg
- 500mg
- ManufacturerMedical Isotopes, Inc.
- Product number59820
- Product descriptionN-[2-[3-Methoxy-4-(phenylmethoxy)phenyl]ethyl]-4-(phenylmethoxy)benzeneacetamide
- Packaging50mg
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM265030
- Product descriptionN-[2-[3-Methoxy-4-(phenylmethoxy)phenyl]ethyl]-4-(phenylmethoxy)benzeneacetamide
- Packaging500mg
- Price$1320
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Medical Isotopes, Inc. | 59820 | N-[2-[3-Methoxy-4-(phenylmethoxy)phenyl]ethyl]-4-(phenylmethoxy)benzeneacetamide | 50mg | $650 | 2021-12-16 | Buy |
| TRC | M265030 | N-[2-[3-Methoxy-4-(phenylmethoxy)phenyl]ethyl]-4-(phenylmethoxy)benzeneacetamide | 500mg | $1320 | 2021-12-16 | Buy |
Properties
Melting point :118 °C
Boiling point :697.8±55.0 °C(Predicted)
Density :1.159±0.06 g/cm3(Predicted)
solubility :Chloroform, Methanol, DCM
form :Solid
pka :15.60±0.46(Predicted)
color :Yellow
Boiling point :697.8±55.0 °C(Predicted)
Density :1.159±0.06 g/cm3(Predicted)
solubility :Chloroform, Methanol, DCM
form :Solid
pka :15.60±0.46(Predicted)
color :Yellow
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|